COST OF BEST SUPPORTIVE CARE FOR NON-SMALL CELL LUNG CANCER PATIENTS - A GERMAN PERSPECTIVE

被引：1
|
作者：
Schmidt, U. [1 ]
Lipp, R. [2 ]
Drechsler, M. [1 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[2] GermanOncol, Hamburg, Germany
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2244
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN86
引用
收藏
页码：A629 / A629
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of oral topotecan plus best supportive care versus best supportive care alone in patients with relapsed small-cell lung cancer (SCLC) in the UK
    O'Brien, Mary E.
    Morris, Stephen
    Papo, Natalie L.
    Lykopoulos, Konstantinos
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S818 - S818
  • [22] Pharmacoeconomic analyses of erlotinib compared with best supportive care (BSC) for the treatment of relapsed non-small cell lung cancer (NSCLC) from the Canadian public health care perspective
    Cote, I
    Leighl, N. B.
    Gyldmark, M.
    Maturi, B.
    VALUE IN HEALTH, 2006, 9 (06) : A279 - A279
  • [23] SECONDARY CARE RESOURCE UTILIZATION AND COST OF CARE AMONG FINNISH NON-SMALL CELL LUNG CANCER PATIENTS
    Loponen, H.
    Vihervaara, V.
    Yla-Viteli, S.
    Torvinen, S.
    Tamminen, K.
    Ylisaukko-oja, T.
    Silvoniemi, M.
    VALUE IN HEALTH, 2018, 21 : S34 - S34
  • [24] DASC-21: a novel geriatric assessment for discriminating best supportive care in older patients with inoperable advanced non-small cell lung cancer
    Yamamoto, Hiroshi
    Sazuka, Manami
    Ishibashi, Masayuki
    Nogimori, Chiemi
    Takada, Kazufumi
    Hamaya, Hironobu
    Yamada, Hirokazu
    Awata, Shuichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (11) : 1628 - 1635
  • [25] Prognostic Significance of EGFR Gene Mutation in Patients With EGFR Mutated Non-small Cell Lung Cancer Who Received Best Supportive Care Alone
    Masuda, Takeshi
    Wakabayashi, Yu
    Nakashima, Taku
    Nishimura, Yoshifumi
    Shimoji, Kiyofumi
    Yamaguchi, Kakuhiro
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Miyamoto, Shintaro
    Senoo, Tadashi
    Iwamoto, Hiroshi
    Ohshimo, Shinichiro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Hattori, Noboru
    ANTICANCER RESEARCH, 2021, 41 (05) : 2661 - 2667
  • [26] Chemotherapy versus best supportive care for extensive small cell lung cancer
    Pelayo Alvarez, Marta
    Gallego Rubio, Oscar
    Bonfill Cosp, Xavier
    Agra Varela, Yolanda
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [27] Chemotherapy versus best supportive care for extensive small cell lung cancer
    Pelayo Alvarez, Marta
    Westeel, Virginie
    Cortes-Jofre, Marcela
    Bonfill Cosp, Xavier
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (11):
  • [28] Pooling clinical and cost outcomes: A case study of best supportive care (BSC) in advanced non small cell lung cancer (NSCLC)
    McAllister, R
    Meddis, D
    Jansen, J
    Ryan, J
    Brown, J
    VALUE IN HEALTH, 2004, 7 (06) : 682 - 683
  • [29] A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)
    Roszkowski, K
    Pluzanska, A
    Krzakowski, M
    Smith, AP
    Saigi, E
    Aasebo, U
    Parisi, A
    Tran, NP
    Olivares, R
    Berille, J
    LUNG CANCER, 2000, 27 (03) : 145 - 157
  • [30] HEALTH CARE RESOURCE UTILIZATION AND COST OF MEDICARE PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
    Yenikomshian, M.
    Hackshaw, M.
    Cai, X.
    Trahey, A.
    Arondekar, B.
    Knoll, S.
    Duh, M. S.
    VALUE IN HEALTH, 2013, 16 (03) : A137 - A137
12345